LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer

NCT00010270 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Esophageal Cancer
Gastric Cancer
Pancreatic Cancer

Interventions

BIOLOGICAL: LMB-9 immunotoxin

Sponsor

University Hospital Freiburg

Collaborators

[object Object]